Comparison of Two Functional Flow Cytometric Assays to Assess P-gp Activity in Acute Leukemia

References

• Harrison, D.J. (1995) "Molecular mechanisms of drug-resistance in tumors", Journal of Pathology, 175, 7–12.
   Google Scholar
• Leith, C.P., Kopecky, K.J., Chen, TM., Eijdems, L., Slovak, ML., McConnell, T.S., et al. (1999) "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study", Blood, 94, 1086–1099.
   Google Scholar
• Legrand, O., Simonin, G., Perrot, J.Y., Zittoun, R., and Marie, J.P. (1998) "Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients", Blood, 91, 4480 — 4488.
   Google Scholar
• van den Heuvel-Eibrink, M.M., Sonneveld, P. and Pieters, R. (2000) "The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia", International Journal of Clinical Pharmacology and Therapeutics, 38, 94–110.
   Google Scholar
• De Moerloose, B., Swerts, K., Benoit, Y., Laureys, G., Loeys, T., Philippe, J., et al. (2003) "The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia", Pediatric Hematology and Oncology, 20, 381— 391.
   Google Scholar
• Kanerva, J., Thrikainen, MI., Makipernaa, A., Riikonen, P., Mottonen, M., Salmi, T.T., et al. (2001) "Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: No evidence of prognostic impact in follow-up", Pediatric Hematology and Oncology, 18, 27–36.
   PubMed Web of Science ®Google Scholar
• Dhooge, C., De Moerloose, B., Laureys, G., Kint, J., Ferster, A., De Bacquer, D., et al. (1999) "P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lympho-blastic leukaemia: results of a 6-year prospective study", British Journal of Haematology, 105, 676–683.
   PubMed Web of Science ®Google Scholar
• Kakihara, T., Tanaka, A., Watanabe, A., Yamamoto, K., Kanto, K., Kataoka, S., et al. (1999) "Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia", Pediatrics International, 41, 641 — 647.
   Google Scholar
• den Boer, ML., Pieters, R., Kazemier, K.M., Rottier, M.M.A., Zwaan, CM., Kaspers, G.J.L., et al. (1998) "Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia", Blood, 91, 2092–2098.
   Google Scholar
• Plasschaert, S.L.A., Vellenga, E., De Bont, E.S.J.M., Van Der Kolk, D.M., Veerman, A.J., Sluiter, W.J., et al. (2003) "High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children", Leukemia and Lymphoma, 44, 85–95.
   Google Scholar
• Beck, W.T., Grogan, TM., Willman, CL., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., et al. (1996) "Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations", Cancer Research, 56, 3010–3020.
   PubMed Web of Science ®Google Scholar
• Efferth, T. (1999) "Testing for tumor drug resistance in the age of molecular medicine. A contribution to the Debate Round-Table on phenotypic and genotypic analysis of multidrug resistance (MDR) in clinical hospital practice", Leukemia, 13, 1627 — 1629.
   Web of Science ®Google Scholar
• Marie, J.P., Huet, S., Faussat, AM., Perrot, J.Y., Chevillard, S., Barbu, V., et al. (1997) "Multicentric evaluation of the MDR phenotype in leukemia", Leukemia, 11, 1086–1094.
   Google Scholar
• Pall, G., Spitaler, M., Hofmann, J., Thaler, J. and Ludescher, C. (1997) "Multidrug resistance in acute leukemia: A comparison of different diagnostic methods", Leukemia, 11, 1067–1072.
   PubMed Web of Science ®Google Scholar
• Legrand, O., Perrot, J.Y., Simonin, G., Baudard, M. and Marie, J.P. (2001) "JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia", Blood, 97, 502— 508.
   Google Scholar
• Cossarizza, A., Baccarini-Contri, M., Kalashnikova, G. and Franceschi, C. (1993) "A new method for cytofluorimetric analysis of mitochondrial membrane potential using J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimida-zol-carbocyanine iodide (iC-1)", Biochemical and Biophysical Research Communications, 197, 40–45.
   PubMed Web of Science ®Google Scholar
• Van Acker, K.L., Van Hove, L.M. and Boogaerts, M.A. (1993) "Evaluation of flow cytometry for multidrug-resistance detection in low resistance K562-cells using daunorubicin and monoclonal antibodies", Cytometry, 14, 736— 746.
   Google Scholar
• Ktihnel, J.M., Perrot, J.Y., Faussat, A.M., Marie, J.P. and Schwaller, M.A. (1997) "Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe", Leukemia, 11, 1147–1155.
   PubMed Web of Science ®Google Scholar
• Zweig, M.H. and Campbell, G. (1993) "Receiver-operating char-acteristic (ROC) plots: a fundamental evaluation tool in clinical medicine", Clinical Chemistry, 39, 561 — 577.
   Google Scholar
• Metz, CE. (1978) "Basic principles of ROC analysis", Seminars in Nuclear Medicine, 8, 283–298.
   PubMed Web of Science ®Google Scholar
• Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Grattringer, C., et al. (1992) "Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123", British Journal of Haematology, 82, 161–168.
   PubMed Web of Science ®Google Scholar
• Leith, C.P., Chen, I.M., Kopecky, K.J., Appelbaum, F.R., Head, D.R., Godwin, J.E., et al. (1995) "Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR — /efflux + and MDR1 + /Ef-flux — cases", Blood, 86, 2329–2342.
   Google Scholar
• Neyfakh, A.A. (1998) "Use of fluorescent dyes as molecular probes for the study of multidrug resistance", Experimental Cell Research, 174, 168–176.
   Google Scholar
• Broxterman, Hi., Lankelma, J., Pinedo, H.M., Eckman, CA., Wahrer, D.C.R., Ossenkoppele, G.J., et al. (1997) "Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia", Leukemia, 11, 1110–1118.
   Google Scholar
• Smiley, S.T., Reers, M., Mottola-Hartshorn, C., Lin, M., Chen, A., Smith, T.W., et al. (1991) "Intracellular heterogeneity in mitochon-drial membrane potentials revealed by a J-aggregate forming lipophilic cation JC-1", Proceedings of the National Academy of Sciences of the United States of America, 88, 3671 —3675.
   Web of Science ®Google Scholar
• Lamy, T., Drenou, B., Grulois, I., Fardel, O., Jacquelinet, C., Goasguen, J., et al. (1995) "Multidrug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay", Leukemia, 9, 1549–1555.
   PubMed Web of Science ®Google Scholar
• Pallis, M., Turzanski, J., Harrison, G., Wheatley, K., Langabeer, S., Burnett, AK., et al. (1999) "Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myelo-blastic leukaemia", British Journal of Haematology, 104, 307 — 312.
   Google Scholar
• Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Buchner, T., Schoch, C., et al. (2000) "Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia", Haematologica, 85, 711–721.
   Google Scholar
• Arceci, R.J. (1993) "Clinical significance of P-glycoprotein in multidrug resistance malignancies", Blood, 81, 2215–2222.
   Google Scholar
• Marie, J.P., Zittoun, R. and Sikic, B.I. (1991) "Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity", Blood, 78, 586 — 592.
   Google Scholar
• De Moerloose, B., Muylaert, A., Gemmel, F., Janssens, A., Poppe, B., Dhooge, C., et al. (2000) "Repetitive analyses of P-glycoprotein in chronic myeloid leukaemia", Acta Clinica Belgica, 55, 215–221.
   PubMed Web of Science ®Google Scholar